The United Kingdom’s Medical Device Authority saw a record increase in medical device testing and approvals in 2025.
According to an article posted on the website of the UK Authority, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) approved 17% more clinical investigations in 2025 compared with 2024. The Agency says that the increases reflect rising investments in emerging health technologies, as well as Agency efforts to provide enhanced support for high-impact technologies, as well as reduced fees for small companies.
Specifically, the MHRA saw a surge in submissions related to neurotechnology and AI-powered medical devices. In 2025, approved neurotechnology studies were double the number approved in 2024 and now account for nearly 25% of all applications.
In addition, studies and approvals of AI-powered medical devices are also on the upswing, with a focus on digital tools that allow for faster and more efficient diagnoses and more personalized care.
Finally, the MHRA reports that it continues to meet its self-imposed deadline of 60 days for its review and approval of clinical investigation applications, with average approval times significantly lower than the 60-day deadline.
The UK Authority article on the increase in medical device testing approvals in the UK is available at https://www.ukauthority.com/articles/uk-sees-record-increase-in-medical-device-testing.